Skip to the page

Data / Federal awards / NAICS 541715 / VENATORX PHARMACEUTICALS INC

VENATORX PHARMACEUTICALS INC: 6 federal contract awards, $15.6 million obligated (FY2024 to FY2027)

VENATORX PHARMACEUTICALS INC (UEI MBBKNBU5DCC6), Malvern, PA, received 6 federal prime contract awards with $15.6 million obligated in fiscal years 2024 to 2027, from 2 agencies under 3 NAICS codes. Its largest buyer is Department of Health and Human Services ($16.1 million) and its largest code is NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.

  • MBBKNBU5DCC6UEI
  • Malvern, PALocation
  • Small BusinessBusiness size
  • 6Contract awards
  • $15.6 millionObligated
  • 2023-10-31First action in window
  • 2026-07-31Latest action

Where the work is

NAICS codes, with the other winners in each.

NAICSIndustryAwardsObligated
541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)1$9.7 million
541714Research and Development in Biotechnology (except Nanobiotechnology)3$6.4 million
541711Research and Development in Biotechnology2$-441,279

Buying agencies

AgencyAwardsObligated
Department of Health and Human Services5$16.1 million
Department of Defense1$-460,217

Obligations by fiscal year

Fiscal yearObligated
FY2024$16.7 million
FY2025$59,933
FY2026$-1,136,345

Contract awards

All 6 awards in fiscal years 2024 to 2027.

Award IDAgencyTypeNAICSWhat it buysObligated in windowAward valueStartsEndsPlace of performanceSource
75N93020C00016Department of Health and Human ServicesDefinitive Contract541715TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.$9,663,738$25,044,893July 1, 2020January 18, 2027Malvern, PAusaspending.gov
75A50119C00007Department of Health and Human ServicesDefinitive Contract541714VENATORX PHARMACEUTICALS, INC.$6,384,601$131,756,814July 17, 2019September 30, 2025Downingtown, PAusaspending.gov
HHSN272201600029CDepartment of Health and Human ServicesDefinitive Contract541711IGF::OT::IGF - ORALLY BIOAVAILABLEβ-LACTAM/β-LACTAMASE INHIBITOR COMBINATION FOR BIODEFENSE AND PUBLIC HEALTH.$18,938$48,517,079September 19, 2016March 31, 2026Malvern, PAusaspending.gov
75A50122C00080Department of Health and Human ServicesDefinitive Contract541714VENATORX PHARMACEUTICALS: ANTIBIOTIC FOR AMR AND BIOTHREAT PATHOGENS$0$72,141,707September 27, 2022December 31, 2028Malvern, PAusaspending.gov
75A50123C00050Department of Health and Human ServicesDefinitive Contract541714VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS.$0$26,449,853September 15, 2023December 31, 2026Malvern, PAusaspending.gov
HDTRA117C0070Department of DefenseDefinitive Contract541711PENICILLIN BINDING PROTEINS IGF::OT::IGF$-460,217$14,716,733August 28, 2017April 30, 2022Malvern, PAusaspending.gov

Also on SpecStream

Updated October 6, 2026. Read from USAspending.gov. Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.